Pilo Shlomo - 02 Mar 2025 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Pilo Shlomo
Issuer symbol: RAPH
Transactions as of: 02 Mar 2025
Net transactions value: +$100,000
Form type: 4
Filing time: 11 Mar 2025, 16:10:13 UTC
Previous filing: 13 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RAPH	Common Stock	Award	$100,000	+200,000	+5.3%	$0.5000	3,983,701	02 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RAPH	Warrant to purchase Common Stock	Award	$0	+100,000	+10%	$0.000000	1,100,000	02 Mar 2025	Common Stock	100,000	$1.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	200,000 shares of Common Stock and 100,000 Warrants to purchase Common Stock of the issuer were acquired by the reporting person for a combined purchase price of $0.50 per share of Common Stock and accompanying Warrant to purchase Common Stock. The Warrants are exercisable immediately and will expire on July 15, 2026.